Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

BACKGROUND: To evaluate the potential treatment for patients with non-small cell lung cancer (NSCLC) and rare malignant pulmonary lymphangitis carcinomatosis (PLC), our study provided a genomic profile and clinical outcome of this group of patients. METHODS: We retrospectively reviewed patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Changqing, Cheng, Wanwan, Zhang, Meiling, Li, Si, Zhao, Lele, Chen, Dongsheng, Qin, Yong, Xiao, Mingzhe, Fang, Shencun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620420/
https://www.ncbi.nlm.nih.gov/pubmed/36324591
http://dx.doi.org/10.3389/fonc.2022.992596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620420/
https://www.ncbi.nlm.nih.gov/pubmed/36324591
http://dx.doi.org/10.3389/fonc.2022.992596

Ejemplares similares